Literature DB >> 4956397

[Neurovirulence of a new attenuated poliovirus type 3 (USOL-D) in a monkey experiment].

F Unterharnscheidt, J Simon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 4956397     DOI： 10.1007/BF00646594

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN： 0028-1042


× No keyword cloud information.
  5 in total

1.  THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.

Authors:  V VONKA; Z JANDA; J SIMON
Journal:  Arch Gesamte Virusforsch       Date:  1964-06-17

2.  PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS.

Authors:  J SIMON
Journal:  Arch Gesamte Virusforsch       Date:  1965

3.  [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES].

Authors:  F UNTERHARNSCHEIDT; O BONIN
Journal:  Arch Psychiatr Nervenkr       Date:  1965-03-01

4.  [ON THE NEUROVIRULENCE TEST OF LIVE POLIOVIRUS VACCINES. I. BASES, TECHNIC AND EVALUATION OF THE RESEARCH ON NEUROVIRULENCE MEASUREMENT IN MONKEYS].

Authors:  O BONIN; F UNTERHARNSCHEIDT
Journal:  Arch Psychiatr Nervenkr       Date:  1964-11-19

5.  Present position of immunization against poliomyelitis with live virus vaccines.

Authors:  A B SABIN
Journal:  Br Med J       Date:  1959-03-14
  5 in total
  2 in total

1.  [On the neurovirulence test of poliomyelitis-live vaccine. 3. Pathomorphology of monkey poliomyelitis through attenuated polioviruses after intrathalamic infection under particular consideration of differences between virus types].

Authors:  F Unterharnscheidt; O Bonin; K Schmidt; I Schmidt
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1966

2.  USOL-D bac (type 3 poliovirus) vaccine studies.

Authors: 
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.